However, in terms of the differentiation of AD from other brain disorders, synaptic proteins (e.g., neurogranin and VILIP-1) are useful, whereas axonal injury markers (e.g., NFL) are not. This evidence concerns the gene VSNL1 and Alzheimer disease.